Supplementary Figure 7 from Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on &lt;i&gt;MIR300&lt;/i&gt; Antiproliferative and PP2A-Activating Functions